BeOne Medicines (ONC) Amortization - Intangibles (2017 - 2024)
BeOne Medicines (ONC) posted quarterly Amortization - Intangibles of $1.2 million for Q2 2024, up 14.49% year-over-year from $1.0 million in Q3 2023, and down 0.51% quarter-over-quarter from $1.2 million in Q1 2024.
BeOne Medicines (ONC) Amortization - Intangibles (2017 - 2024) Analysis & Trends
BeOne Medicines (ONC) has reported Amortization - Intangibles for 8 consecutive years, with $1.2 million the latest figure, recorded in Q2 2024.
- In Q2 2024, Amortization - Intangibles rose 14.49% year-over-year to $1.2 million; the TTM figure through Jun 2024 stood at $7.6 million (up 91.06% YoY), while the FY2023 annual figure was $7.2 million, up 82.07% from the prior year.
- Amortization - Intangibles retreated to $1.2 million in Q2 2024 per ONC's latest filing, from $1.2 million in the prior quarter.
- Across five years, Amortization - Intangibles topped out at $3.0 million in Q4 2023 and bottomed at $187000.0 in Q3 2020.
- Historically, Amortization - Intangibles has averaged $896444.4 across 5 years, with a median of $977500.0 in 2022.
- Annual changes were most pronounced in 2020 — Amortization - Intangibles sank 43.5% — and 2022, when it jumped 442.55%.
- BeOne Medicines' Amortization - Intangibles stood at $188000.0 in 2020, then surged by 335.64% to $819000.0 in 2021, then gained by 18.32% to $969000.0 in 2022, then soared by 205.16% to $3.0 million in 2023, then slumped by 60.2% to $1.2 million in 2024.
- Business Quant data shows ONC's Amortization - Intangibles at $1.2 million in Q2 2024, $1.2 million in Q1 2024, and $3.0 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 1.18 Mn |
| Mar 31, 2024 | 1.18 Mn |
| Dec 31, 2023 | 2.96 Mn |
| Sep 30, 2023 | 2.27 Mn |
| Jun 30, 2023 | 1.03 Mn |
| Mar 31, 2023 | 986,000.00 |
| Dec 31, 2022 | 969,000.00 |
| Sep 30, 2022 | 987,000.00 |
| Jun 30, 2022 | 1.00 Mn |
| Mar 31, 2022 | 1.02 Mn |
| Dec 31, 2021 | 819,000.00 |
| Sep 30, 2021 | 404,000.00 |
| Jun 30, 2021 | 304,000.00 |
| Mar 31, 2021 | 188,000.00 |
| Dec 31, 2020 | 188,000.00 |
| Sep 30, 2020 | 187,000.00 |
| Jun 30, 2020 | 188,000.00 |
| Mar 31, 2020 | 283,000.00 |
| Dec 31, 2019 | 332,000.00 |
| Sep 30, 2019 | 331,000.00 |